glp-1 läkemedel Gubra initiates collaboration on new antagonist Swissmedic issues warning against falsified

However, it remains uncertain whether these changes result from direct anti-inflammatory effects of GLP-1 receptor activation or are secondary to weight loss and improved metabolic health

Hypoglycemia in diabetes

Medical Complications: Common Alcohol-Related Concerns

NAFLD comprises a group of diseases that include non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and related cirrhosis, and it is often associated with insulin resistance and metabolic syndrome

Animal studies indicate that Vildagliptin, an oral DPP-4 inhibitor, has a promising effect on T1DM, stimulating the neogenesis of pancreatic beta cells 7

Starvation and fasting: biochemical aspects